Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

High Doses of Targeted Radiation with Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Do Not Correlate with Incidence of Mucositis, Febrile Neutropenia or Sepsis in the Prospective, Randomized Phase 3 Sierra Trial for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-134624

Published: 2020

Journal Articles

Personalized Targeted Radioimmunotherapy with Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia Results in Successful Donor Hematopoietic Cells Engraftment with the Timing of Engraftment Not Related to the Radiation Dose Delivered

Blood (2020) 136 (Supplement 1): 42–44.

https://doi.org/10.1182/blood-2020-134948

Published: 2020

Journal Articles

Re-Induction and Targeted Conditioning with Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Leads to High Rates of Transplantation and Successful Engraftment in Older Patients with Active, Relapsed or Refractory (rel/ref) AML after Failure of Chemotherapy and Targeted Agents: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 Sierra Trial

Blood (2019) 134 (Supplement_1): 5642.

https://doi.org/10.1182/blood-2019-122776

Published: 2019

Journal Articles

Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease

Blood (2019) 134 (Supplement_1): 4516.

https://doi.org/10.1182/blood-2019-127325

Published: 2019

Journal Articles

β2- Adrenergic Signaling Regulates Graft Versus Host Disease after Allogenic Transplantation While Preserving Graft Versus Leukemia Effect

Hemn Mohammadpour, PhD DVM, Joseph L. Sarow, BS, George L. Chen, MD, Cameron R. MacDonald, BS, Umesh Sharma, MD, Megan M. Herr, PhD, Theresa E. Hahn, PhD, Elizabeth A. Repasky, PhD, Philip L. McCarthy, MD

Blood (2019) 134 (Supplement_1): 1915.

https://doi.org/10.1182/blood-2019-123139

Published: 2019

Journal Articles

Identification of Immune Phenotypes Associated with Improved Progression Free and Overall Survival for Patients with Multiple Myeloma Treated with Autologous Hematopoietic Cell Transplantation

Christine M. Ho, MD, Theresa Hahn, PhD, Paul K. Wallace, MS, PhD, Yali Zhang, Ahmad Fora, MD, George L. Chen, MD, Sarah A. Holstein, MD PhD, Patrick Mellors, Benjamin McCarthy, Sophia R. Balderman, MD, Philip L. McCarthy, MD

Blood (2016) 128 (22): 3454.

https://doi.org/10.1182/blood.V128.22.3454.3454

Published: 2016

Journal Articles

Effect of Immune Reconstitution on Survival after Autologous Hematopoietic Cell Transplant for B-Cell Non-Hodgkin Lymphoma

Pallawi Torka, MD, Paul K. Wallace, MS, PhD, Yali Zhang, George L. Chen, MD, Sophia R. Balderman, MD, Bruno Paiva, PhD, Christine M. Ho, MD, Maureen Ross, MD, Francisco J. Hernandez-Ilizaliturri, MD, Philip L. McCarthy, MD, Theresa Hahn, PhD

Blood (2015) 126 (23): 3173.

https://doi.org/10.1182/blood.V126.23.3173.3173

Published: 2015

Journal Articles

Perforin Is Important For Both CD4+ and CD8+ T Cell-Mediated Graft-Versus-Tumor Effect But Plays Differential Roles In CD4+ and CD8+ T Cell Expansion After Allogeneic Transplantation

Nicholas Leigh, Guanglin Bian, PhD, Wei Du, George L. Chen, MD, Hong Liu, MD, PhD, Philip L. McCarthy, Jr., MD, Xuefang Cao, PhD

Blood (2013) 122 (21): 3255.

https://doi.org/10.1182/blood.V122.21.3255.3255

Published: 2013

Journal Articles

Analysis Of Immune Cell Populations Before and After Autologous Hematopoietic Stem Cell Transplant For Multiple Myeloma: Association With Early Recovery Of Absolute Lymphocyte Count and Progression-Free Survival

Theresa Hahn, PhD, Yali Zhang, MPH, Bruno Paiva, George L. Chen, MD, Paul K. Wallace, MS, PhD, Philip L. McCarthy, Jr., MD

Blood (2013) 122 (21): 3348.

https://doi.org/10.1182/blood.V122.21.3348.3348

Published: 2013

Journal Articles

Short Course of Levofloxacin During Neutropenia Prevents Early and Late Bacteremia Episodes After Allogeneic Blood and Marrow Transplantation (alloBMT)

Sophia Francis, Theresa Hahn, PhD, Yali Zhang, MPH, Nikolaos Almyroudis, MD, George L. Chen, MD, Hong Liu, MD, PhD, Maureen Ross, MD, PhD, Brahm H Segal, MD, Philip L. McCarthy, Jr., MD

Blood (2012) 120 (21): 4141.

https://doi.org/10.1182/blood.V120.21.4141.4141

Published: 2012

Journal Articles

A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease

George L. Chen, MD, Paul A. Carpenter, MD, Raewyn Broady, MBChB, FRACP, Tara B. Gregory, MD, Sally Arai, MD, Laura Johnston, MD, Mary E.D. Flowers, MD, Jan H. Beumer, PharmD, PhD, Jodie Mendolsohn, Xin Zhou, Spenser H. Perloff, Joanne M Otani, RN, MSN, David B Miklos, MD, PhD

Blood (2011) 118 (21): 1986.

https://doi.org/10.1182/blood.V118.21.1986.1986

Published: 2011

Journal Articles

Micro Dose Methotrexate (MTX) Is Equivalent to Full Dose MTX and Superior to No MTX for Acute Graft-Versus-Host Disease Prophylaxis

George L. Chen, MD, Yali Zhang, MPH, Hong Liu, MD, PhD, Maureen Ross, MD, PhD, Theresa Hahn, PhD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 3038.

https://doi.org/10.1182/blood.V118.21.3038.3038

Published: 2011

Journal Articles

Optimizing the Timing of Allogeneic Blood or Marrow Transplantation (BMT) in a Prospective Cohort of Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hong Liu, MD, PhD, Yali Zhang, MPH, Theresa Hahn, PhD, Julie Thomas, DO, Meir Wetzler, MD, Eunice S. Wang, MD, Lise Hernandez, MPH, Maureen Ross, MD, PhD, George L. Chen, MD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 3096.

https://doi.org/10.1182/blood.V118.21.3096.3096

Published: 2011

Journal Articles

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Hong Liu, MD, PhD, Theresa Hahn, PhD, Gregory Wilding, PhD, Adrienne Groman, Barbara Bambach, MD, Meghan Higman, MD, Maureen Ross, MD, PhD, George L. Chen, MD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 4570.

https://doi.org/10.1182/blood.V118.21.4570.4570

Published: 2011

Journal Articles

Protein Microarrays Identify Elevated Allogeneic Antibodies In Association with Extensive Chronic Graft Versus Host Disease

John F. Tan, MD, George L. Chen, MD, Persis P. Wadia, PhD, Marc Coram, PhD, David Miklos, MD, PhD

Blood (2010) 116 (21): 2344.

https://doi.org/10.1182/blood.V116.21.2344.2344

Published: 2010

Journal Articles

Chronic Graft-Versus-Host Disease Responds to Imatinib and Pre Transplant/Donor Anti-PDGFRA Antibodies Predict for Chronic Graft-Versus-Host Disease Development

George L. Chen, MD, Sally Arai, MD, Mary E.D. Flowers, MD, Joanne M Otani, RN, MSN, BS, Marc Coram, PhD, Alex McMillan, PhD, Judith A Shizuru, PhD, MD, Laura Johnston, MD, David Miklos, MD, PhD

Blood (2010) 116 (21): 2320.

https://doi.org/10.1182/blood.V116.21.2320.2320

Published: 2010

Journal Articles

A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis.

George L. Chen, MD, Sally Arai, MD, Mary E.D. Flowers, MD, Joanne Otani, RN, MSN, Ethan C. Cheng, Alex McMillan, PhD, Wen-Kai Weng, MD, PhD, Judith Shizuru, PhD, MD, Laura Johnston, MD, David Miklos, MD, PhD

Blood (2009) 114 (22): 3304.

https://doi.org/10.1182/blood.V114.22.3304.3304

Published: 2009

Journal Articles

IgG Allotypes Reveal That Antimicrobial Humoral Immunity Persists after Reduced-Intensity Hematopoietic Cell Transplantation

Julie R. Boiko, Bita Sahaf, PhD, Antonia M.S. Mueller, MD, George L. Chen, MD, Dolly Tyan, PhD, David B. Miklos, MD, PhD

Blood (2008) 112 (11): 349.

https://doi.org/10.1182/blood.V112.11.349.349

Published: 2008

Journal Articles

Erythropoietin Signaling Inhibits Long Term Marrow Reconstitution.

George L. Chen, MD, Kotung Chang, PhD, Xiaosong Huang, PhD, Gerald J. Spangrude, PhD, Josef T. Prchal, MD

Blood (2006) 108 (11): 3194.

https://doi.org/10.1182/blood.V108.11.3194.3194

Published: 2006

Journal Articles

Tlr4 Is Monoallelically Expressed in Human BFU-E and CFU-E and May Have Application as a Clonality Marker in Hematological Disorders Due to Somatic Mutations in Both Males and Females.

George L. Chen, MD, Enli Liu, MD, Sabina Swierczek, PhD, Josef T. Prchal, MD

Blood (2006) 108 (11): 3619.

https://doi.org/10.1182/blood.V108.11.3619.3619

Published: 2006

NARROW

High Doses of Targeted Radiation with Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Do Not Correlate with Incidence of Mucositis, Febrile Neutropenia or Sepsis in the Prospective, Randomized Phase 3 Sierra Trial for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Personalized Targeted Radioimmunotherapy with Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia Results in Successful Donor Hematopoietic Cells Engraftment with the Timing of Engraftment Not Related to the Radiation Dose Delivered

Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease

β2- Adrenergic Signaling Regulates Graft Versus Host Disease after Allogenic Transplantation While Preserving Graft Versus Leukemia Effect

Identification of Immune Phenotypes Associated with Improved Progression Free and Overall Survival for Patients with Multiple Myeloma Treated with Autologous Hematopoietic Cell Transplantation

Effect of Immune Reconstitution on Survival after Autologous Hematopoietic Cell Transplant for B-Cell Non-Hodgkin Lymphoma

Perforin Is Important For Both CD4+ and CD8+ T Cell-Mediated Graft-Versus-Tumor Effect But Plays Differential Roles In CD4+ and CD8+ T Cell Expansion After Allogeneic Transplantation

Analysis Of Immune Cell Populations Before and After Autologous Hematopoietic Stem Cell Transplant For Multiple Myeloma: Association With Early Recovery Of Absolute Lymphocyte Count and Progression-Free Survival

Short Course of Levofloxacin During Neutropenia Prevents Early and Late Bacteremia Episodes After Allogeneic Blood and Marrow Transplantation (alloBMT)

A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease

Micro Dose Methotrexate (MTX) Is Equivalent to Full Dose MTX and Superior to No MTX for Acute Graft-Versus-Host Disease Prophylaxis

Optimizing the Timing of Allogeneic Blood or Marrow Transplantation (BMT) in a Prospective Cohort of Relapsed or Refractory Acute Myeloid Leukemia (AML)

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Protein Microarrays Identify Elevated Allogeneic Antibodies In Association with Extensive Chronic Graft Versus Host Disease

Chronic Graft-Versus-Host Disease Responds to Imatinib and Pre Transplant/Donor Anti-PDGFRA Antibodies Predict for Chronic Graft-Versus-Host Disease Development

A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis.

IgG Allotypes Reveal That Antimicrobial Humoral Immunity Persists after Reduced-Intensity Hematopoietic Cell Transplantation

Erythropoietin Signaling Inhibits Long Term Marrow Reconstitution.

Tlr4 Is Monoallelically Expressed in Human BFU-E and CFU-E and May Have Application as a Clonality Marker in Hematological Disorders Due to Somatic Mutations in Both Males and Females.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only